Details

Last Funding Type

Series D

Last Funding Money Raised

$74M

Industries

Biotechnology,Genetics,Health Care,Pharmaceutical

Founded date

Jan 1, 2000

Number Of Employee

51 - 100

Operating Status

Active

Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.